[HTML][HTML] British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of …
A proportion of people living with common variable immunodeficiency disorders develop
granulomatous-lymphocytic interstitial lung disease (GLILD). We aimed to develop a …
granulomatous-lymphocytic interstitial lung disease (GLILD). We aimed to develop a …
Anaplastic large cell lymphoma (ALCL) and breast implants: breaking down the evidence
X Ye, K Shokrollahi, WM Rozen, R Conyers… - … Research/Reviews in …, 2014 - Elsevier
Systemic anaplastic large cell lymphoma (ALCL) is a distinct disease classification
provisionally sub-divided into ALCL, Anaplastic Lymphoma Kinase (ALK)+ and ALCL, ALK …
provisionally sub-divided into ALCL, Anaplastic Lymphoma Kinase (ALK)+ and ALCL, ALK …
Ethnicity and the prostate cancer experience: a qualitative metasynthesis
Objectives To summarize black and minority ethnic (BME) patients' and partners
experiences of prostate cancer by examining the findings of existing qualitative studies …
experiences of prostate cancer by examining the findings of existing qualitative studies …
Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice
Acute myeloid leukemia (AML) is a molecularly diverse malignancy with a poor prognosis
whose largest subgroup is characterized by somatic mutations in NPM1, which encodes …
whose largest subgroup is characterized by somatic mutations in NPM1, which encodes …
Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised …
INTRODUCTION AND AIM: In a randomised trial investigating the effects of regular use of
health-related quality of life (HRQOL) in oncology practice, we previously reported an …
health-related quality of life (HRQOL) in oncology practice, we previously reported an …
Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis
A Downing, EJA Morris, M Richards… - Journal of clinical …, 2015 - eprints.soton.ac.uk
Purpose This population-level study was conducted to define the health-related quality of life
(HRQL) of individuals living with and beyond colorectal cancer (CRC) and to identify factors …
(HRQL) of individuals living with and beyond colorectal cancer (CRC) and to identify factors …
[HTML][HTML] Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy
PJ Campbell, D Bareford, WN Erber… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose Essential thrombocythemia (ET) manifests substantial interpatient heterogeneity in
rates of thrombosis, hemorrhage, and disease transformation. Bone marrow histology …
rates of thrombosis, hemorrhage, and disease transformation. Bone marrow histology …
[HTML][HTML] Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes
Background Little is known about health-related quality of life (HRQOL) following treatment
for bladder cancer (BC). Objective To determine this, we undertook a cross-sectional survey …
for bladder cancer (BC). Objective To determine this, we undertook a cross-sectional survey …
[HTML][HTML] Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts
Heterozygous somatic mutations affecting the spliceosome gene SF3B1 drive age-related
clonal hematopoiesis, myelodysplastic syndromes (MDS) and other neoplasms. To study …
clonal hematopoiesis, myelodysplastic syndromes (MDS) and other neoplasms. To study …
Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study
A Downing, P Wright, L Hounsome, P Selby… - The Lancet …, 2019 - thelancet.com
Background Little is known about the health-related quality of life (HRQOL) of men living
with advanced prostate cancer. We report population-wide functional outcomes and HRQOL …
with advanced prostate cancer. We report population-wide functional outcomes and HRQOL …